Efficacy and Safety of Garadacimab in Combination with Standard of Care Treatment in Patients with Severe COVID-19

被引：0
|
作者：
Alberto Papi
Renee D. Stapleton
Paul M. Shore
Mihai Alexandru Bica
Younan Chen
Michael Larbig
Tobias Welte
机构：
[1] University of Ferrara,Respiratory Department
[2] University of Vermont,Pulmonary and Critical Care Medicine
[3] CSL Behring,Clinical Development
[4] CSL Behring Innovation,Global Clinical Safety and Pharmacovigilance
[5] CSL Behring,Biostatistics
[6] CSL Behring AG,Clinical Development
[7] Hannover Medical School,Department of Pulmonary and Infectious Diseases
来源：
Lung | 2023年 / 201卷
关键词：
COVID-19; Critically ill patients; Inflammation; Respiratory disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：159 / 170
页数：11
相关论文
共 50 条
  • [21] Safety and Efficacy of Ivermectin and Doxycycline Monotherapy and in Combination in the Treatment of COVID-19: A Scoping Review
    Bhowmick, Subhrojyoti
    Dang, Amit
    Vallish, B. N.
    Dang, Sumit
    [J]. DRUG SAFETY, 2021, 44 (06) : 635 - 644
  • [22] Safety and Efficacy of Ivermectin and Doxycycline Monotherapy and in Combination in the Treatment of COVID-19: A Scoping Review
    Subhrojyoti Bhowmick
    Amit Dang
    B. N. Vallish
    Sumit Dang
    [J]. Drug Safety, 2021, 44 : 635 - 644
  • [23] Palliative care for patients with severe covid-19
    Ting, Ruth
    Edmonds, Polly
    Higginson, Irene J.
    Sleeman, Katherine E.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2020, 370
  • [24] Safety and Efficacy of Paxlovid in Pediatric Intensive Care Unit Patients with COVID-19
    Fan, Panpan
    Ming, Meixiu
    Liu, Tingyan
    Chen, Weiming
    Wang, Yixue
    Wang, Dan
    Lu, Guoping
    Yan, Gangfeng
    [J]. CURRENT MEDICINAL CHEMISTRY, 2024,
  • [25] Remdesivir versus Standard of Care in Moderate to Severe COVID-19 Patients: A Retrospective Study
    Kumar, J. M. Jeetendra
    Vaibhav, S. B.
    Avinash, H. R.
    Pratheek, P.
    [J]. JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2021, 15 (04)
  • [26] Evaluation of the efficacy and safety of hydroxychloroquine in comparison with chloroquine in moderate and severe patients with COVID-19
    Li, Qiuyu
    Cui, Cheng
    Xu, Fei
    Zhao, Jianping
    Li, Nan
    Li, Haichao
    Wang, Tianbing
    Zhang, Hua
    Liu, Na
    Wei, Yudong
    Niu, Xiaoye
    Xu, Yan
    Dong, Jianping
    Yao, Xueting
    Wang, Xiaohong
    Chen, Yahong
    Li, Haiyan
    Song, Chunli
    Qiao, Jie
    Liu, Dongyang
    Shen, Ning
    [J]. SCIENCE CHINA-LIFE SCIENCES, 2021, 64 (04) : 660 - 663
  • [27] Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial
    Ameri, Ali
    Asadi, Masoomeh Frouz
    Ziaei, Ava
    Vatankhah, Majid
    Safa, Omid
    Kamali, Manoochehr
    Fathalipour, Mohammad
    Mahmoodi, Masoumeh
    Hassanipour, Soheil
    [J]. INFLAMMOPHARMACOLOGY, 2023, 31 (01) : 265 - 274
  • [28] Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients
    Okumus, Nurullah
    Demirturk, Nese
    Cetinkaya, Riza Aytac
    Guener, Rahmet
    Avci, Ismail Yasar
    Orhan, Semiha
    Konya, Petek
    Saylan, Bengue
    Karalezli, Ayseguel
    Yamanel, Levent
    Kayaaslan, Bircan
    Yilmaz, Guelden
    Savasci, UEmit
    Eser, Fatma
    Taskin, Guerhan
    [J]. BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [29] Efficacy and Safety of Ivermectin and Hydroxychloroquine in Patients with Severe COVID-19: A Randomized Controlled Trial
    Beltran Gonzalez, Jose Lenin
    Gonzalez Gamez, Mario
    Mendoza Enciso, Emanuel Antonio
    Esparza Maldonado, Ramiro Josue
    Hernandez Palacios, Daniel
    Duenas Campos, Samuel
    Ovalle Robles, Itzel
    Macias Guzman, Mariana Jocelyn
    Garcia Diaz, Andrea Lucia
    Gutierrez Pena, Cesar Mauricio
    Martinez Medina, Lucila
    Monroy Colin, Victor Antonio
    Arreola Guerra, Jose Manuel
    [J]. INFECTIOUS DISEASE REPORTS, 2022, 14 (02) : 160 - 168
  • [30] Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial
    Ali Ameri
    Masoomeh Frouz Asadi
    Ava Ziaei
    Majid Vatankhah
    Omid Safa
    Manoochehr Kamali
    Mohammad Fathalipour
    Masoumeh Mahmoodi
    Soheil Hassanipour
    [J]. Inflammopharmacology, 2023, 31 : 265 - 274
12345